we are very angry and there is no reason to think that a...

we are very angry and there is no reason to think that a partnership agreement will generate a 60% reduction with the halving of the beneficiary company's capitalization. however unhappy the agreement may be, this transfer in 12 sessions is irrational and unjustified, at least for what we know. Obviously, if the company is hiding something from us, the assessment changes, but I have no reason to date matured in 10 years of investment, to doubt that the leadership of Neuren is in bad faith.
with this premise it seems to me that, sitting after session, the hypothesis that the stock is the object of a downward speculation by someone who has / had shares in considerable quantities is reinforced. the main suspect falls on American institutions that obtained 1.3 million shares as a result of the exclusivity agreement and although they have agreed to pay them 4 times the current market price; only this last detail should make us reflect, but even more so that they were assigned without indicating the beneficiary in the related 3B, favoring in fact the exchange on the market without having to trace anything.
in conclusion to this market price I believe that none of Neuren's convinced supporters sell their shares; at this point there is to decide whether to continue to believe unconditionally in the capacity of Treagus or the market and its behavior; obviously the answers will have them in the next months and for what I already expect as significant first indications, from 1 September onwards.